We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Some Transfusions May Do More Harm Than Good

By LabMedica International staff writers
Posted on 09 May 2012
The lack of clear guidelines for ordering blood transfusions means there is still wide variation in the use of transfusions and frequent use of transfused blood in patients who do not need it. More...


The resulting overuse of blood is problematic because blood is a scarce and expensive resource and because recent studies have shown that surgical patients do no better, and may do worse, if given transfusions prematurely or unnecessarily.

Scientists at Johns Hopkins University School of Medicine (Baltimore, MD, USA) examined the electronic anesthesia records of more than 48,000 surgical patients at the adjacent Johns Hopkins Hospital over the 18 months from February 2010 to August 2011. Overall, 2,981 patients (6.2%) were given blood transfusions during surgery. The study found wide variation among surgeons and among anesthesiologists, compared to their peers, and how quickly they order blood.

In a healthy adult, a normal hemoglobin level, the quantity of red blood cells carrying oxygen through the body, is approximately 14 g/dL. The guidelines state that when a patient's hemoglobin level falls below 6 or 7 g/dL, a patient will benefit from a transfusion and that if the levels are above 10, a patient does not need a transfusion. But when blood levels are in-between, there has been little consensus about what to do. The study found that the use of erythrocyte salvage, fresh frozen plasma, and platelets varied threefold to fourfold among individual surgeons compared with their peers performing the same surgical procedure.

Blood transfusion, which introduces foreign substances into the body, initiates a series of complex immune reactions. Patients often develop antibodies to transfused red blood cells making it more difficult to find a match if future transfusions are needed. Transfused blood also has a suppressive effect on the immune system, which increases the risk of infections, including pneumonia and sepsis.

Blood is in short supply and expensive. In the USA it costs USD 278 to buy a unit of blood from the American Red Cross (Washington DC, USA) for example, and as much as USD 1,100 for the nonprofit to acquire, test, store and transport. The US national social insurance program, Medicare pays just USD 180 for that unit of blood.

Steven M. Frank, MD, leader of the study, said, "Transfusion is not as safe as people think. Over the past five years, studies have supported giving less blood than we used to, and our study shows that practitioners have not caught up. Blood conservation is one of the few areas in medicine where outcomes can be improved, risk reduced, and costs saved all at the same time. Nothing says it's better to give a patient more blood than is needed.” The study was published on April 23, 2012, in the journal Anesthesiology.

Related Links:

Johns Hopkins University School of Medicine
American Red Cross



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.